LUNG logo

LUNG
Pulmonx Corp

647
Mkt Cap
$54.91M
Volume
228,784.00
52W High
$5.46
52W Low
$1.13
PE Ratio
-0.96
LUNG Fundamentals
Price
$1.28
Prev Close
$1.30
Open
$1.30
50D MA
$1.46
Beta
1.14
Avg. Volume
792,589.07
EPS (Annual)
-$1.33
P/B
0.99
Rev/Employee
$305,733.11
$76.27
Loading...
Loading...
News
all
press releases
Pulmonx (LUNG) Projected to Post Earnings on Wednesday
Pulmonx (NASDAQ:LUNG) will be releasing its Q1 2026 earnings after the market closes on Wednesday, April 29. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-4-29-pulmonx-co-stock...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Pulmonx Corporation (NASDAQ:LUNG) Short Interest Update
Pulmonx Corporation (NASDAQ:LUNG - Get Free Report) saw a significant drop in short interest in the month of March. As of March 31st, there was short interest totaling 2,857,097 shares, a drop of...
MarketBeat·7d ago
News Placeholder
Hims & Hers Health (HIMS) Soars 11.1%: Is Further Upside Left in the Stock?
Hims & Hers Health (HIMS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks·7d ago
News Placeholder
Pulmonx (NASDAQ:LUNG) Stock Price Up 2.3% - Still a Buy?
Pulmonx (NASDAQ:LUNG) Shares Up 2.3% - Time to Buy...
MarketBeat·17d ago
News Placeholder
Pulmonx Corporation (NASDAQ:LUNG) Given Consensus Recommendation of "Hold" by Analysts
Shares of Pulmonx Corporation (NASDAQ:LUNG - Get Free Report) have earned a consensus recommendation of "Hold" from the eight research firms that are presently covering the stock, MarketBeat Ratings...
MarketBeat·17d ago
News Placeholder
TruBridge (TBRG) Beats Q4 Earnings Estimates
TruBridge (TBRG) delivered earnings and revenue surprises of +92.68% and -0.50%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·23d ago
News Placeholder
Pulmonx Corporation (NASDAQ:LUNG) Given Average Rating of "Hold" by Brokerages
Pulmonx Corporation (NASDAQ:LUNG - Get Free Report) has received an average recommendation of "Hold" from the eight research firms that are covering the firm, Marketbeat.com reports. One investment...
MarketBeat·1mo ago
News Placeholder
Pulmonx (NASDAQ:LUNG) Price Target Cut to $5.00 by Analysts at Canaccord Genuity Group
Canaccord Genuity Group lowered their price target on Pulmonx from $6.00 to $5.00 and set a "buy" rating for the company in a research report on Thursday...
MarketBeat·2mo ago
News Placeholder
Pulmonx (NASDAQ:LUNG) CEO Sells $96,972.59 in Stock
Pulmonx Corporation (NASDAQ:LUNG - Get Free Report) CEO Glendon French III sold 67,813 shares of the stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price...
MarketBeat·2mo ago
News Placeholder
Pulmonx (NASDAQ:LUNG) Issues Quarterly Earnings Results
Pulmonx (NASDAQ:LUNG - Get Free Report) posted its quarterly earnings data on Wednesday. The company reported ($0.25) earnings per share for the quarter, topping analysts' consensus estimates of...
MarketBeat·2mo ago
<
1
2
...
>

Latest LUNG News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.